UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma

Journal of neuro-oncology, 2018-07, Vol.138 (3), p.499-508

2018

Volltextzugriff (PDF)

EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling

Neuro-oncology (Charlottesville, Va.), 2021-04, Vol.23 (4), p.611-624

2021

Volltextzugriff (PDF)

Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma

Journal of experimental & clinical cancer research, 2019-04, Vol.38 (1), p.166-166, Article 166

2019

Volltextzugriff (PDF)

Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy

Journal of controlled release, 2022-05, Vol.345, p.696-708

2022

Volltextzugriff (PDF)

TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT

Neuro-oncology (Charlottesville, Va.), 2021-03, Vol.23 (3), p.435-446

2021

Volltextzugriff (PDF)

Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme

Journal of experimental & clinical cancer research, 2019-08, Vol.38 (1), p.380-380, Article 380

2019

Volltextzugriff (PDF)

Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress

Cancer letters, 2024-04, Vol.586, p.216666-216666, Article 216666

2024

Volltextzugriff (PDF)

Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2012-12, Vol.14 (12), p.1452-1464

2012

Volltextzugriff (PDF)

The role of trimethylation on histone H3 lysine 27 (H3K27me3) in temozolomide resistance of glioma

Brain research, 2025-01, Vol.1846, p.149252, Article 149252

2025

Volltextzugriff (PDF)

Unveiling the role of TAGLN2 in glioblastoma: From proneural-mesenchymal transition to Temozolomide resistance

Cancer letters, 2024-08, Vol.598, p.217107, Article 217107

2024

Volltextzugriff (PDF)

Implication of lncRNA ZBED3-AS1 downregulation in acquired resistance to Temozolomide and glycolysis in glioblastoma

European journal of pharmacology, 2023-01, Vol.938, p.175444-175444, Article 175444

2023

Volltextzugriff (PDF)

Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance

Oncotarget, 2015-12, Vol.6 (38), p.40998-41017

2015

Volltextzugriff (PDF)

Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance

Cancer science, 2021-11, Vol.112 (11), p.4736-4747

2021

Volltextzugriff (PDF)

Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization

Neuro-oncology (Charlottesville, Va.), 2018-01, Vol.20 (2), p.236-248

2018

Volltextzugriff (PDF)

Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761

Cellular and molecular neurobiology, 2022-04, Vol.42 (3), p.695-708

2022

Volltextzugriff (PDF)

Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway

Phytomedicine (Stuttgart), 2022-05, Vol.99, p.154016-154016, Article 154016

2022

Volltextzugriff (PDF)

Dissecting the mechanism of temozolomide resistance and its association with the regulatory roles of intracellular reactive oxygen species in glioblastoma

Journal of biomedical science, 2021-03, Vol.28 (1), p.18-18, Article 18

2021

Volltextzugriff (PDF)

The role of BCL2L13 in glioblastoma: turning a need into a target

Biochemistry and cell biology, 2024-04, Vol.102 (2), p.127-134

2024

Volltextzugriff (PDF)

MiR‐16‐5p is frequently down‐regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy

Neuropathology and applied neurobiology, 2019-08, Vol.45 (5), p.441-458

2019

Volltextzugriff (PDF)

Involvement of cell shape and lipid metabolism in glioblastoma resistance to temozolomide

Acta pharmacologica Sinica, 2023-03, Vol.44 (3), p.670-679

2023

Volltextzugriff (PDF)

PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response

Biochimica et biophysica acta. Molecular basis of disease, 2022-06, Vol.1868 (6), p.166382-166382, Article 166382

2022

Volltextzugriff (PDF)

Overexpression of PPM1B inhibited chemoresistance to temozolomide and proliferation in glioma cells

Cell biology international, 2024-02, Vol.48 (2), p.143-153

2024

Volltextzugriff (PDF)

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma

Frontiers in oncology, 2016-10, Vol.6, p.222-222

2016

Volltextzugriff (PDF)

LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma

Aging (Albany, NY.), 2019-08, Vol.11 (16), p.6053-6068

2019

Volltextzugriff (PDF)

Temozolomide-resistant Glioblastoma Depends on HDAC6 Activity Through Regulation of DNA Mismatch Repair

Anticancer research, 2019-12, Vol.39 (12), p.6731-6741

2019

Volltextzugriff (PDF)

1 – 25 von 1.351

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.229)
Mit Volltextzugriff
(1.257)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.198)
Temozolomide
(1.144)
Life Sciences & Biomedicine
(1.103)
Humans
(930)
Glioblastoma
(721)
Cell Line, Tumor
(630)
Oncology
(554)
Brain Cancer
(494)
Drug Resistance
(492)
Chemotherapy
(458)
Apoptosis
(425)
Glioblastoma - Drug Therapy
(421)
Brain Neoplasms - Drug Therapy
(418)
Tumors
(418)
Dacarbazine - Analogs & Derivatives
(411)
Glioma
(385)
Temozolomide - Pharmacology
(383)
Animals
(366)
Drug Resistance, Neoplasm
(354)
Antineoplastic Agents, Alkylating - Pharmacology
(339)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

International Journal Of Molecular Sciences
(45)
British Journal Of Cancer
(40)
Cell Death & Disease
(36)
Cancers
(33)
Scientific Reports
(30)
Journal Of Neuro-Oncology
(28)
Neuro-Oncology
(28)
Plos One
(28)
Cell Death And Disease
(25)
Cells
(25)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(22)
... seit 30 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma

EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling

Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma

Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy

TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT

Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme

Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress

Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma

The role of trimethylation on histone H3 lysine 27 (H3K27me3) in temozolomide resistance of glioma

Unveiling the role of TAGLN2 in glioblastoma: From proneural-mesenchymal transition to Temozolomide resistance

Implication of lncRNA ZBED3-AS1 downregulation in acquired resistance to Temozolomide and glycolysis in glioblastoma

Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance

Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance

Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization

Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761

Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway

Dissecting the mechanism of temozolomide resistance and its association with the regulatory roles of intracellular reactive oxygen species in glioblastoma

The role of BCL2L13 in glioblastoma: turning a need into a target

MiR‐16‐5p is frequently down‐regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy

Involvement of cell shape and lipid metabolism in glioblastoma resistance to temozolomide

PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response

Overexpression of PPM1B inhibited chemoresistance to temozolomide and proliferation in glioma cells

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma

LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma

Temozolomide-resistant Glioblastoma Depends on HDAC6 Activity Through Regulation of DNA Mismatch Repair

Suchergebnisse filtern